Zobrazeno 1 - 10
of 18
pro vyhledávání: '"René Druckmann"'
Autor:
Nicolas Rygaloff, Jean Marc Ayoubi, David Elia, Eleonora Russo, Niko Heiss, Jean Marc Bohbot, Nicolas Berreni, René Druckmann, Hugues Geoffrion, Philippe Descamps, François Haab, Marco Gambiacciani
Publikováno v:
Hormone Molecular Biology and Clinical Investigation. 41
Urinary incontinence is a common health problem that impacts the quality of life of women at different ages. Its physiopathology is not unequivocal, and it is necessary to consider the stress urinary incontinence (SUI), the overactive bladder syndrom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c6f47c384ad3a3d27e7c564e4f83fe1
https://doi.org/10.1515/hmbci-2020-0012
https://doi.org/10.1515/hmbci-2020-0012
Autor:
Eleonora Russo, Jean Marc Bohbot, Nicolas Berreni, Hugues Geoffrion, René Druckmann, Marco Gambacciani, Niko Heiss, François Haab, Nicolas Rygaloff, David Elia
Publikováno v:
Hormone Molecular Biology and Clinical Investigation. 41
The purpose of this publication is to summarize the results of the vaginal erbium:yttrium-aluminum-garnet (Er:YAG) Smooth® laser (VEL) on the vaginal atrophy component of the genitourinary syndrome of menopause (GSM). GSM has two categories of clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b641059bff859d7ef3d4225131735d
https://doi.org/10.1515/hmbci-2019-0024
https://doi.org/10.1515/hmbci-2019-0024
Publikováno v:
Hormone molecular biology and clinical investigationReferences. 41(3)
Ovarian cancer has a high mortality rate. The most common serous type spreads rapidly throughout the peritoneal cavity when 5-year survival is 10%. If diagnosed in earlier stages where the cancer is still confined to the ovary, this survival rate is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405e61ddfbd98f317124aa4c93e983e2
https://pubmed.ncbi.nlm.nih.gov/31661436
https://pubmed.ncbi.nlm.nih.gov/31661436
Autor:
René Druckmann, Adolf E. Schindler
Publikováno v:
Hormone Molecular Biology and Clinical Investigation. 37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3db8087db520e985c972f9e872c29f6
https://doi.org/10.1515/hmbci-2019-2066
https://doi.org/10.1515/hmbci-2019-2066
Autor:
René Druckmann, Adolf E. Schindler
Publikováno v:
Hormone molecular biology and clinical investigation. 32(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8386c799c8ba9a173225ca268675f81
https://pubmed.ncbi.nlm.nih.gov/28937964
https://pubmed.ncbi.nlm.nih.gov/28937964
Publikováno v:
Menopause. 22:1212-1214
Tamoxifen, used for treatment and chemoprevention of breast cancer, is converted to 4-hydroxy-tamoxifen and other metabolites by cytochrome P450 (CYP) enzymes. It can often initiate or exacerbate vasomotor symptoms (VMS). Selective serotonin reuptake
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd70b97ebf186dd89f1771b36fcdc890
https://doi.org/10.1097/gme.0000000000000535
https://doi.org/10.1097/gme.0000000000000535
Autor:
René Druckmann
Publikováno v:
Contraception. 79:272-281
Chlormadinone acetate (CMA) is a derivative of progesterone (17α-acetoxy-6-chloro-4,6-pregnadiene-3,20-dione), first synthesized in 1961 and is used as an orally effective progestogen in hormone replacement therapy (HRT), and in combination with eth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af2dfd4e75f0db6c54d15b40da3c1738
https://doi.org/10.1016/j.contraception.2008.10.017
https://doi.org/10.1016/j.contraception.2008.10.017
Autor:
Jorge R. Pasqualini, Jos H.H. Thijssen, Johannes C. Huber, Adolf E. Schindler, Carlo Campagnoli, K.-W. Schweppe, René Druckmann
Publikováno v:
Maturitas. 61:171-180
Besides the natural progestin, progesterone, there are different classes of progestins, such as retroprogesterone (i.e. dydrogesterone), progesterone derivatives (i.e. medrogestone) 17α-hydroxyprogesterone derivatives (i.e. chlormadinone acetate, cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bc73fa7fbe29ddb45c564170d9157dd
https://doi.org/10.1016/j.maturitas.2008.11.013
https://doi.org/10.1016/j.maturitas.2008.11.013
Autor:
René Druckmann
Publikováno v:
Gynecological Endocrinology. 23:53-61
The role of progestins in long-term treatment has recently been under scrutiny, in particular as their effects on organs other than the endometrium, such as the breast or the cardiovascular system, could give rise to undesirable reactions. The use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5815baa071999b356d501a7832dd6bac
https://doi.org/10.1080/09513590701585045
https://doi.org/10.1080/09513590701585045
Autor:
René Druckmann
Publikováno v:
Maturitas. 46:59-69
Nowadays, when the available scientific data on the in vivo effects of progestins on mammary gland tissue remain controversial, it is of utmost importance to establish adequate criteria to evaluate their actions. One of the reasons for this situation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549ed2d300818d880fe52df4b27220d7
https://doi.org/10.1016/j.maturitas.2003.09.020
https://doi.org/10.1016/j.maturitas.2003.09.020